Loss of CD14 leads to disturbed epithelial-B cell crosstalk and impairment of the intestinal barrier after E. coli Nissle monoassociation

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Basic, Marijana ^a   Buettner, Manuela ^a   Keubler, Lydia M ^a   Smoczek, Anna ^a   Bruesch, Inga ^a   Buchheister, Stephanie ^a   Bleich, André ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE RECEPTOR; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; B LYMPHOCYTE; BACTERIUM ADHERENCE; CELL COMMUNICATION; DEFICIENCY; EPITHELIUM CELL; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; BACTERIAL ADHESION; CELL COMMUNICATION; EPITHELIAL CELLS; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; LIPOPOLYSACCHARIDE RECEPTORS; MICE; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 4;

EID: 85040767033     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-19062-7     Document Type: Article

References (59)

1. Sartor, R. B. &Mazmanian, S. K. Intestinal Microbes inInflammatory Bowel Diseases. Am J Gastroenterol Suppl 1, 15-21 (2012).
2. Kaser, A., Zeissig, S. &Blumberg, R. S. Inflammatory bowel disease. Annual review of immunology 28, 573-621, https://doi. org/10.1146/annurev-immunol-030409-101225 (2010).
3. Rescigno, M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends in immunology 32, 256-264, https://doi.org/10.1016/j.it.2011.04.003 (2011).
4. Baumgart, D. C. &Dignass, A. U. Intestinal barrier function. Current opinion in clinical nutrition and metabolic care 5, 685-694, https://doi.org/10.1097/01.mco.0000038813.16540.3b (2002).
5. Maynard, C. L., Elson, C. O., Hatton, R. D. &Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241, https://doi.org/10.1038/nature11551 (2012).
6. Peterson, L. W. &Artis, D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nature reviews. Immunology 14, 141-153, https://doi.org/10.1038/nri3608 (2014).
7. Matter, K. &Balda, M. S. Signalling to and from tight junctions. Nature reviews. Molecular cell biology 4, 225-236, https://doi. org/10.1038/nrm1055 (2003).
8. Suzuki, T. Regulation of intestinal epithelial permeability by tight junctions. Cellular and molecular life sciences: CMLS 70, 631-659, https://doi.org/10.1007/s00018-012-1070-x (2013).
9. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. &Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241, https://doi.org/10.1016/j.cell.2004.07.002 (2004).
10. Fukata, M. &Arditi, M. The role of pattern recognition receptors in intestinal inflammation. Mucosal immunology 6, 451-463, https://doi.org/10.1038/mi.2013.13 (2013).
11. Lavelle, E. C., Murphy, C., O'Neill, L. A. &Creagh, E. M. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal immunology 3, 17-28, https://doi.org/10.1038/mi.2009.124 (2010).
12. Maloy, K. J. &Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306, https://doi. org/10.1038/nature10208 (2011).
13. Elson, C. O. &Cong, Y. Host-microbiota interactions in inflammatory bowel disease. Gut microbes 3, 332-344, https://doi. org/10.4161/gmic.20228 (2012).
14. Cader, M. Z. &Kaser, A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62, 1653-1664, https://doi.org/10.1136/gutjnl-2012-303955 (2013).
15. Burisch, J. &Munkholm, P. Inflammatory bowel disease epidemiology. Current opinion in gastroenterology 29, 357-362, https://doi. org/10.1097/MOG.0b013e32836229fb (2013).
16. Podolsky, D. K. The current future understanding of inflammatory bowel disease. Best practice &research. Clinical gastroenterology 16, 933-943 (2002).
17. Haziot, A. et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. Journal of immunology 141, 547-552 (1988).
18. de Buhr, M. F. et al. Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflammatory bowel diseases 15, 1824-1836, https://doi.org/10.1002/ibd.21030 (2009).
19. Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S. &Richter-Dahlfors, A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. The Journal of experimental medicine 195, 559-570 (2002).
20. Funda, D. P. et al. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infection and immunity 69, 3772-3781, https://doi.org/10.1128/IAI.69.6.3772-3781.2001 (2001).
21. de Buhr, M. F. et al. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiological genomics 25, 426-434, https://doi.org/10.1152/physiolgenomics.00022.2005 (2006).
22. Buchheister, S. et al. CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function. The American journal of pathology 187, 1106-1120, https://doi.org/10.1016/j.ajpath.2017.01.012 (2017).
23. Klein, W. et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scandinavian journal of gastroenterology 37, 189-191 (2002).
24. Baumgart, D. C. et al. The c.1-260C T promoter variant of CD14 but not the c.896A G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion 76, 196-202, https://doi.org/10.1159/000112646 (2007).
25. Zschemisch, N. H., Brusch, I., Hambusch, A. S. &Bleich, A. Transcription Factor SP2 Enhanced the Expression of Cd14 in Colitis-Susceptible C3H/HeJBir. PloS one 11, e0155821, https://doi.org/10.1371/journal.pone.0155821 (2016).
26. Vidal, K., Labeta, M. O., Schiffrin, E. J. &Donnet-Hughes, A. Soluble CD14 in human breast milk and its role in innate immune responses. Acta odontologica Scandinavica 59, 330-334 (2001).
27. Lee, J. W., Paape, M. J., Elsasser, T. H. &Zhao, X. Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infection and immunity 71, 4034-4039 (2003).
28. Andrukhov, O. et al. Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to P. gingivalis Lipopolysaccharide. PloS one 11, e0160848, https://doi.org/10.1371/journal.pone.0160848 (2016).
29. Nissle, A. Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Medizinische Klinik 2, 29-33 (1918).
30. Schultz, M. et al. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clinical and diagnostic laboratory immunology 11, 581-587, https://doi. org/10.1128/CDLI.11.3.581-587.2004 (2004).
31. Grabig, A. et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infection and immunity 74, 4075-4082, https://doi.org/10.1128/IAI.01449-05 (2006).
32. Kruis, W. et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623, https://doi.org/10.1136/gut.2003.037747 (2004).
33. Bleich, A. et al. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background. International journal of experimental pathology 89, 45-54, https://doi.org/10.1111/j.1365-2613.2007.00560.x (2008).
34. Johansen, F. E., Braathen, R. &Brandtzaeg, P. Role of J chain in secretory immunoglobulin formation. Scandinavian journal of immunology 52, 240-248 (2000).
35. Asano, M. &Komiyama, K. Polymeric immunoglobulin receptor. Journal of oral science 53, 147-156 (2011).
36. Filipp, D. et al. Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proceedings of the National Academy of Sciences of the United States of America 98, 603-608, https://doi.org/10.1073/pnas.98.2.603 (2001).
37. Wenneras, C. et al. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. Journal of immunology 164, 3214-3221 (2000).
38. Ukena, S. N. et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PloS one 2, e1308, https:// doi.org/10.1371/journal.pone.0001308 (2007).
39. Zyrek, A. A. et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cellular microbiology 9, 804-816, https://doi. org/10.1111/j.1462-5822.2006.00836.x (2007).
40. Alvarez, C. S., Badia, J., Bosch, M., Gimenez, R. &Baldoma, L. Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells. Frontiers in microbiology 7, 1981, https://doi.org/10.3389/fmicb.2016.01981 (2016).
41. Cario, E., Gerken, G. &Podolsky, D. K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374, https://doi.org/10.1053/j.gastro.2007.02.056 (2007).
42. Cario, E. Barrier-protective function of intestinal epithelial Toll-like receptor Mucosal immunology 1(Suppl 1), S62-66, https://doi. org/10.1038/mi.2008.47 (2008).
43. Gibson, D. L. et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cellular microbiology 10, 388-403, https://doi.org/10.1111/j.1462-5822.2007.01052.x (2008).
44. Ranoa, D. R., Kelley, S. L. &Tapping, R. I. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex. The Journal of biological chemistry 288, 9729-9741, https://doi.org/10.1074/jbc.M113.453266 (2013).
45. Zhang, X. et al. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. Journal of immunology 175, 4834-4838 (2005).
46. Lord, S. J., Rajotte, R. V., Korbutt, G. S. &Bleackley, R. C. Granzyme B: a natural born killer. Immunological reviews 193, 31-38 (2003).
47. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H. &Ley, T. J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977-987 (1994).
48. Gronbach, K. et al. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host. Infection and immunity 78, 3036-3046, https://doi.org/10.1128/IAI.00218-10 (2010).
49. Johansen, F. E. &Kaetzel, C. S. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal immunology 4, 598-602, https:// doi.org/10.1038/mi.2011.37 (2011).
50. Bruno, M. E. et al. Regulation of the polymeric immunoglobulin receptor in intestinal epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis. Immunological investigations 39, 356-382, https://doi.org/10.3109/08820131003622809 (2010).
51. Schneeman, T. A. et al. Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses. Journal of immunology 175, 376-384 (2005).
52. Brandtzaeg, P. Homeostatic impact of indigenous microbiota and secretory immunity. Beneficial microbes 1, 211-227, https://doi. org/10.3920/BM2010.0009 (2010).
53. Hopken, U. E., Achtman, A. H., Kruger, K. &Lipp, M. Distinct and overlapping roles of CXCR5 and CCR7 in B-1 cell homing and early immunity against bacterial pathogens. Journal of leukocyte biology 76, 709-718, https://doi.org/10.1189/jlb.1203643 (2004).
54. Rawlings, D. J., Schwartz, M. A., Jackson, S. W. &Meyer-Bahlburg, A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nature reviews. Immunology 12, 282-294, https://doi.org/10.1038/nri3190 (2012).
55. Baumgarth, N. How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth. Immunological reviews 255, 82-94, https://doi.org/10.1111/imr.12094 (2013).
56. Baumgarth, N. et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. The Journal of experimental medicine 192, 271-280 (2000).
57. Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C. &Chen, J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. The Journal of experimental medicine 188, 2381-2386 (1998).
58. Paciorkowski, N., Porte, P., Shultz, L. D. &Rajan, T. V. B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. The Journal of experimental medicine 191, 731-736 (2000).
59. Basic, M. et al. Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflammatory bowel diseases 20, 431-443, https://doi.org/10.1097/01.MIB.0000441346.86827.ed (2014).